Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current Update of Phytotherapeutic Agents in the Treatment of COVID-19: In-Silico Based Virtual Screening Approach for the Development of Antiviral Drug.
Ramesh V, Kulkarni SA, Velusamy P, Devadasan V, Devaraju P, Rajnish KN, Madhavan T, Anbu P, Ramasamy P, Sundarraj R. Ramesh V, et al. Among authors: kulkarni sa. Front Biosci (Landmark Ed). 2022 Apr 2;27(4):123. doi: 10.31083/j.fbl2704123. Front Biosci (Landmark Ed). 2022. PMID: 35468682 Free article. Review.
Update on Management of Ductal Carcinoma in Situ.
Buchheit JT, Schacht D, Kulkarni SA. Buchheit JT, et al. Among authors: kulkarni sa. Clin Breast Cancer. 2023 Dec 26:S1526-8209(23)00325-7. doi: 10.1016/j.clbc.2023.12.010. Online ahead of print. Clin Breast Cancer. 2023. PMID: 38216382 Review.
The Hospitalist Movement 25 Years Later.
Kulkarni SA, Wachter RM. Kulkarni SA, et al. Annu Rev Med. 2024 Jan 29;75:381-390. doi: 10.1146/annurev-med-051022-043301. Epub 2023 Oct 6. Annu Rev Med. 2024. PMID: 37802086 Free article. Review.
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19.
Allais C, Bernhardson D, Brown AR, Chinigo GM, Desrosiers JN, DiRico KJ, Hotham I, Jones BP, Kulkarni SA, Lewis CA, Lira R, Loach RP, Morse PD, Mousseau JJ, Perry MA, Peng Z, Place DW, Rane AM, Samp L, Singer RA, Wang Z, Weisenburger GA, Yayla HG, Zanghi JM. Allais C, et al. Among authors: kulkarni sa. Org Process Res Dev. 2023 Feb 3:acs.oprd.2c00375. doi: 10.1021/acs.oprd.2c00375. Online ahead of print. Org Process Res Dev. 2023. PMID: 37552749 Review.
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG. Rastogi A, et al. Among authors: kulkarni sa. JAMA Netw Open. 2023 May 1;6(5):e2311509. doi: 10.1001/jamanetworkopen.2023.11509. JAMA Netw Open. 2023. PMID: 37184839 Free article. Clinical Trial.
103 results